Novel blood return system cuts blood loss by 97% in pulmonary embolism procedure

The first comparative analysis from the ENGULF (A Safety and Feasibility Single-Arm Study of a Novel Catheter Thrombectomy Device For the Treatment of Pulmonary Embolism) trial shows that using blood return during continuous aspiration thrombectomy dramatically reduces blood loss by 97%, while maintaining hemodynamic efficacy and improving procedural efficiency.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup